Posted by Administrator on January 11th, 2006 — in Celebrex Top News
NEW YORK (AFP) — US drug giant Pfizer will immediately and indefinitely stop advertising its painkiller Celebrex to consumers in the wake of research linking high doses to increased heart attack risk, The New York Times reported.
Some magazine advertisements may appear for a few more weeks owing to the long lead time in magazine […]
No Comments »
Posted by Administrator on January 11th, 2006 — in Celebrex Top News
NEW YORK (AFP) — US drug giant Pfizer will immediately and indefinitely stop advertising its painkiller Celebrex to consumers in the wake of research linking high doses to increased heart attack risk.
Some magazine advertisements may appear for a few more weeks owing to the long lead time in magazine advertising, Pfizer spokeswoman Mariann Caprino […]
No Comments »
Posted by Administrator on January 11th, 2006 — in Celebrex Top News
GAITHERSBURG, Md. — Members of a Food and Drug Administration advisory committee on Wednesday criticized drugmaker Pfizer for a lack of long-term safety data about its blockbuster arthritis drug Celebrex.
The committee is meeting to discuss the future of Celebrex, Bextra and other COX-2 inhibitor drugs not yet on the market. The group is expected to […]
No Comments »
Posted by Administrator on January 11th, 2006 — in Celebrex Top News
A consumer advocate Monday accused Pfizer, the maker of Celebrex, of hiding the results of a study in which patients who took the drug were 3 1/2 times more likely to have a stroke, heart attack or other serious cardiovascular problem than those on a placebo.
Sidney Wolfe of Public Citizen’s Health Research Group had petitioned […]
No Comments »